Journal of Biological Chemistry
Editors' PicksCRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology
Cited by (0)
This work was supported by a grant from the National Institutes of Health Common Fund to Promote the Glycosciences (Grant 5R21 AI123161) and received additional support from National Institutes of Health Grants R01-GM037539 (to C. M. W.), R01-GM084383 (to C. M. W.), P41-GM103490 (to L. W., senior investigator), and 8P41-GM103390 (Resource for Integrated Glycotechnology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
This article was selected as one of our Editors' Picks.
This article contains Tables S1–S5 and Figs. S1–S7.
- 7
M. Mandalasi, H. W. Kim, K. Rahman, P. Zhao, N. Daniel, M. O. Sheikh, H. van der Wel, D. Thieker, T. H. Ichikawa, J. Glushka, L. Wells, Z. A. Wood, and C. M. West, manuscript in preparation.
- 8
Please note that the JBC is not responsible for the long-term archiving and maintenance of this site or any other third party hosted site.
- 1
Both authors contributed equally to this work.
- 2
Present address: New Materials Institute, University of Georgia, Athens, GA 30602.
- 3
Present address: George Washington University School of Public Health, Washington, D. C. 20009.
- 4
Supported in part by National Institutes of Health T32 Training Grant AI060546 (to the Center for Tropical and Emerging Global Diseases).